Dominion Capital LLC - 27 Dec 2024 SCHEDULE 13D Report for ReShape Lifesciences Inc. Common Stock, par value $0.001 per share (RSLS)

Filing Manager
Dominion Capital LLC
Reporting Manager
Dominion Capital LLC
Security
ReShape Lifesciences Inc. Common Stock, par value $0.001 per share
Symbol
RSLS
Shares outstanding
791K shares
Disclosed Ownership
78.3K shares
Ownership
9.9%
Form type
SCHEDULE 13D
Filing time
07 Jan 2025, 14:52:58 UTC
Date of event
27 Dec 2024
Next filing
04 Apr 2025
SEC
View on sec.gov

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Dominion Capital LLC 9.9% 78.3K 0 78.3K /s/ Mikhail Gurevich Mikhail Gurevich, Authorized Signatory 0001532798
Dominion Capital GP LLC 9.9% 78.3K 0 78.3K /s/ Mikhail Gurevich Mikhail Gurevich, Authorized Signatory
Dominion Capital Holdings LLC 9.9% 78.3K 0 78.3K /s/ Mikhail Gurevich Mikhail Gurevich, Authorized Signatory
Ascent Partners Fund LLC 9.9% 78.3K 0 78.3K /s/ Alon Brenner Alon Brenner, Authorized Signatory
Mikhail Gurevich 9.9% 78.3K 0 78.3K /s/ Mikhail Gurevich Mikhail Gurevich
Gennadiy Gurevich 9.9% 78.3K 0 78.3K /s/ Gennadiy Gurevich Gennadiy Gurevich
Alon Brenner 9.9% 78.3K 0 78.3K /s/ Alon Brenner Alon Brenner